The Effect of Menstration on GnRH Agonist Treatment for the Uterine Myoma
![]() |
Han, Soo-Kyung
(Department of Pharmacy, Chungnam National University Hospital)
Lee, Myung-Koo (College of Pharmacy, Chungbuk National University) Han, Song-Yi (College of Pharmacy, Chungbuk National University) Park, Mi-Sook (Department of Pharmacy, Chungnam National University Hospital) Lim, Sung-Cil (College of Pharmacy, Chungbuk National University) |
1 | Ross, R. K., Pike, M. C, Vessey, M. P., Bull, D., Yeates, D. and Casagrande, J. T. : Risk factors for uterine fibroids: reduced risk associated with oral contraceptives [published erratum in BMJ 1986; 293: 1027]. BMJ 293, 359 (1986) |
2 | Marshall, L. M., Spiegelman, D., Goldman, M. B., Manson, J. E., Colditz, G. A., Barbieri, R. L., Stampfer, M. J. and Hunter, D. J. : A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril. 70, 432 (1998) |
3 | Kjerulff, K. H., Langenberg, P., Seidman, J. D., Stolley, R D. and Guzinski, G. M.: Uterine leiomyomas: racial differences in severity, symptoms and age at diagnosis. J. Reprod. Med. 41, 483 (1996) |
4 | 백원민, 정승우, 조성식, 임광호 : 자궁근종의 임상적 고찰. 대한산부회지 20, 1047 (1983) |
5 | Filicori, M., Hall, D. A., Loughlin, J. S., Rivier, J., Vale, W. and Crowley, W. F. Jr.: A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue. Am. J. Obstet. Gynecol. 147, 726 (1983) |
6 | 정진국, 고만석, 정병욱, 이호형, 최호준, 신승권 : 자궁근종에 관한 임상통계학적 고찰. 대한산부회지 41, 210 (1998) |
7 | 유한기 : 자궁근종의 임상병리학적 연구. 대한산부회지 30, 1287 (1987) |
8 | Donnez, J., Nisolle, M., Grandjean, E, Gillerot, S. and Clerckx, E : The role of GnRH agonists in the endoscopic treatment of endometriosis and fibromyomas. Contracept. Fertil Sex. 21, 59 (1993) |
9 | Friedman, A. J., Daly, M., Juneau-Norcross, M., Gleason, R., Rein, M. S. and LeBoff, M. : Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years. Hum. Reprod. 9, 1618 (1994) |
10 | Donnez, J. and Jadoul, E : What are the implications of myomas on fertility? A need for a debate? Hum. Reprod. 17,101 (2002) |
11 | Englund, K., Blanck, A., Gustavsson, I., Lundkvist, U., Sjoblom, P., Norgren, A. and Lindblom, B. : Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadatrophin-releasing hormone treatment. J. Clin. Endocrinol. Metab. 83, 4092 (1998) |
12 | Sadan, O., Ginath, S., Sofer, D., Rotmensch, S., Debby, A., Glezerman, M. and Zakut, H. : The role of tamoxifen in the treatment of symptomatic uterine leiomyomata-a pilot study. Eur. J. Obstet. Gynecol. Reprod. Biol. 96, 183 (2001) |
13 | Perry, C. M. and Brogden, R. N. : Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in benign gynaecological disorders. Drugs. 51, 319 (1996) |
14 | Kiiholma, E, Tuimala, R., Kivinen, S., Korhonen, M. and Hagman, E. : Comparison of the gonadotrophin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progesterone add-back therapy in the treatment of endometriosis. Fertil Steril. 64, 903 (1995) |
15 | Kiesel, L. A., Rody, A., Greb, R. R. and Szilagyi, A. : Clinical use of GnRH analogues. Clin. Endocrinol. 56, 677 (2002) |
16 | Paraziini, E, La Vecchia, C, Negri, E., Cecchetti, G. and Fedele, L. : Epidemiologic characteristics of women with uterine fibroids: a case control study. Obstet. Gynecol. 72, 853 (1988) |
17 | Lethaby, A., Vollenhoven, B. and Sowter, M. : Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane. Database. Syst. Rev. 2, CD000547 (2001) |
18 | 이란옥, 박경일, 김종철, 박무실, 김철, 지정희 : 자궁근종에 대한 임상통계학적 관찰. 대한산부회지 30, 213 (1987) |
19 | Pickersgill, A., Kingsland, C. R., Garden, A. S. and Farquharson, R. G.: Multiple gestation following gonadotrophin releasing hormone therapy for the treatment of minimal endometriosis. Br. J. Obstet. Gynaecol. 101, 260 (1994) |
20 | Stewart, E. A. : Uterine fibroids. Lancet. 357, 293 (2001) DOI ScienceOn |
21 | West, C. E, Lumsden, M. A., Lawson, S., Williamson, J. and Baird, D. T.: Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot. Fertil Steril. 48, 45 (1987) |
22 | Carr, B. R., Marshburn, E B., Weatherall, E T, Bradshaw, K. D., Breslau, N. A., Byrd, W, Roark, M. and Steinkampf, M. E : An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial. J. Clin. Endocrinol. Metab. 76, 1217 (1993) |
23 | 김동호, 김홍관, 선진규, 박병삼, 임헌정 : 자궁근종에 대한 임상 및 병리학적 연구. 대한산부회지 37, 1205 (1994) |
24 | Lumsden, M. A. : The effects of steroid hormones on the growth of uterine leiomyomata. In: Motta, M. and Serio, M. eds. Sex hormones and antihormones in endocrine dependent pathology. Basic and clinical aspects. Excerpta Medica (1994) |
25 | 이종학 : 자궁근종에 대한 임상적 및 병리학적 연구. 대한산부회지 30, 213 (1987) |
26 | Cramer, S. E and Patel, A. : The frequency of uterine leiomyomas. Am. J. Clin. Pathol. 94, 435 (1990) |
27 | 서호성, 남철, 김창수, 장병곤, 양희동, 박세준 : 자궁근종에 대한 임상통계학적 연구. 대한산부회지 39, 1047 (1996) |
28 | 육순광, 정기성, 이숙환, 김성도, 안재영 : 자궁근종의 임상병리학적 고찰. 대한산부회지 27, 184 (1984) |
29 | Early breast cancer trialists' collaborative group. Ovarian ablation in early breast cancer: overview of the randomised trials. Lancet. 348, 1189 (1996) |
30 | Garcia, C. R. and Tureck, R. W : Submucosal leiomyomas and infertility. Fertil Steril. 42, 16 (1984) |
31 | Shaw, R. W : New approaches to the management of fibroids. Curr. Opin. Obstet. Gynecol. 3, 859 (1991) |
32 | Buttram, V C. Jr. and Reiter, R. C. : Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril. 36, 433 (1981) |
33 | Donnez, J., Schrurs, B., Gillerot, S., Sandow, J. and Clerckx, E : Treatment of uterine fibroids with implants of gonadotrophin-releasing hormone agonist: assessment by hysterography. Fertil Steril. 51, 947 (1989) |
34 | Jonathan, S. B., Eli, Y. A. and Paula, A. H.: Novak's gynecology 12th. Williams & Wilkins, Baltimore, p. 374 (1996) |
35 | Cramer, S. F. and Patel, A. : The frequency of uterine leiomyomas. Am. J. Clin. Pathol. 94, 435 (1990) |
36 | Rice, J. E, Kay, H. H. and Mahony, B. S. ; The clinical significance of uterine leiomyomas in pregnancy. Am. J. Obstet. Gynecol. 160, 1212 (1989) |
37 | Friedman, A. J., Barbieri, R. L., Doubilet, E M., Fine, C. and Schiff, I. : A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri. Fertil Steril. 49, 404 (1988) |
38 | Stovall, T. G., Muneyyirci-Delale, O., Summit, R. L. Jr. and Scialli, A. R. : GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: a randomized controlled trial. Obstet. Gynecol. 86, 64 (1995) |
39 | Burroughs, K. D., Fuchs-Young, R., Davis, B. and Walker, C. L.: Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat. Biol. Reprod. 63, 1322 (2000) |
40 | Marshall, L. M., Spiegelman, D., Barbieri, R. L., Goldman, M. B., Manson, J. E., Colditz, G. A., Willett, W C. and Hunter, D. J. : Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet. Gynecol. 90, 967 (1997) |
![]() |